Markets
| Security | Price | % | Buy | Sell | Target price ▼ | Potential |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. |
€847.40
24.04.24 |
0.380% | 33 | 1 | €957.22 | 12.960% |
| Eli Lilly Corp. |
€684.10
24.04.24 |
-1.580% | 47 | 0 | €753.63 | 10.164% |
| arGEN X BV |
€349.90
23.04.24 |
1.570% | 1 | 0 | €470.00 | 34.324% |
| Medpace Holdings Inc |
€371.80
24.04.24 |
1.500% | 9 | 0 | €421.61 | 13.396% |
| Vertex Pharmaceuticals Inc. |
€374.55
24.04.24 |
-0.820% | 40 | 2 | €382.71 | 2.177% |
| Icon plc |
€288.90
24.04.24 |
0.770% | 15 | 0 | €318.99 | 10.417% |
| Madrigal Pharmaceuticals inc. |
€191.10
24.04.24 |
-5.560% | 3 | 0 | €315.00 | 64.835% |
| Biogen Inc. |
€188.70
24.04.24 |
3.720% | 43 | 1 | €298.48 | 58.175% |
| Amgen Inc. |
€255.20
24.04.24 |
0.230% | 23 | 0 | €293.65 | 15.066% |
| United Therapeutics |
€219.10
23.04.24 |
1.050% | 15 | 0 | €289.92 | 32.323% |
| BeiGene Ltd ADR |
€130.00
23.04.24 |
5.690% | 8 | 1 | €255.89 | 96.839% |
| IQVIA Holdings Inc. |
€223.00
23.04.24 |
1.290% | 1 | 0 | €240.00 | 7.623% |
| Alnylam Pharmace. |
€134.35
24.04.24 |
-0.510% | 35 | 0 | €236.30 | 75.882% |
| Zoetis Inc. A |
€141.00
24.04.24 |
1.230% | 20 | 1 | €201.64 | 43.004% |
| Johnson & Johnson |
€138.84
24.04.24 |
-0.470% | 32 | 1 | €196.74 | 41.700% |
| Jazz Pharmaceuticals plc |
€101.20
24.04.24 |
-1.460% | 21 | 0 | €183.25 | 81.081% |
| Repligen Corp. |
€156.80
24.04.24 |
-0.590% | 12 | 0 | €182.96 | 16.684% |
| Novo Nordisk A/S |
€185.00
12.09.23 |
-0.080% | 4 | 0 | €182.50 | -1.351% |
| AbbVie Inc. |
€156.84
24.04.24 |
-1.010% | 18 | 1 | €175.79 | 12.081% |
| Krystal Biotech |
€148.60
24.04.24 |
0.170% | 16 | 0 | €173.22 | 16.567% |
| AstraZeneca plc |
€133.40
24.04.24 |
1.410% | 1 | 0 | €165.00 | 23.688% |